Split Course Hyperfractionated Accelerated Radio-Chemotherapy (SCHARC) for patients with advanced head and neck cancer: Influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis

BACKGROUND: The advantage of hyperfractionated accelerated radiation therapy for advanced head and neck cancer has been reported. Furthermore, randomized trials and meta-analyses have confirmed the survival benefit of additional chemotherapy to radiotherapy. We retrospectively analyzed the efficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stadler, Peter, Putnik, Kurt, Kreimeyer, Thore, Sprague, Lisa D, Koelbl, Oliver, Schäfer, Christof
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702360/
https://www.ncbi.nlm.nih.gov/pubmed/17150114
http://dx.doi.org/10.1186/1471-2407-6-279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702360/
https://www.ncbi.nlm.nih.gov/pubmed/17150114
http://dx.doi.org/10.1186/1471-2407-6-279

Ejemplares similares